Rapid emergence of oseltamivir resistance

Emerging Infectious Diseases

Volumn 16, Issue 4, 2010, Pages 723-725

  Sy, Cheng Len ^a   Lee, Susan Shin Jung ^a,b   Liu, Ming Tsan ^c   Tsai, Hung Ching ^a,b   Chen, Yao Shen ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; LEVOFLOXACIN; OSELTAMIVIR; SULTAMICILLIN; VIRUS SIALIDASE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; CASE REPORT; DNA SEQUENCE; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LETTER; MALE; NONHUMAN; PANDEMIC; RESPIRATORY DISTRESS SYNDROME; SPECIES COMPARISON; VIRUS ISOLATION; VIRUS MUTATION; VIRUS PNEUMONIA; VIRUS RESISTANCE; VIRUS STRAIN;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; JAPAN; MALE; OSELTAMIVIR; YOUNG ADULT;

EID: 77950651355     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1604.091706     Document Type: Letter

References (9)

1. Nicholls H. Pandemic influenza: the inside story. PLOS Biology. 2006;4:156-60. Epub 2006 Feb 14. DOI: 10.1371/journal.pbio.0040156
2. World Health Organization. Pandemic (H1N1) 2009: update 70 [cited 2009 Oct 22]. http://www.who.int/csr/don/2009_10_16/en/index.html
3. World Health Organization. Oseltamivirresistant pandemic (H1N1) 2009 influenza virus, October 2009. Wkly Epidemiol Rec. 2009;84:453-9.
4. Chen H, Cheung CL, Tai H, Zhao P, Chan JFW, Cheng VCC, et al. Oseltamivirresistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis. 2009;15:1970-2.
5. Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season [cited 2009 Oct 22]. http://www.cdc.gov/h1n1flu/recommendations.htm
6. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients-Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:893-6.
7. World Health Organization. Clinical features of severe cases of pandemic influenza [cited 2009 Oct 22]. http://www.who.int/csr/disease/swineflu/notes/h1n1_clinical_features_20091016/en/
8. Escuret V, Frobert E, Bouscambert-Duchamp M, Sabatier M, Grog I, Valette M, et al. Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors. J Clin Virol. 2008;41:25-8. DOI: 10.1016/j.jcv.2007.10.019
9. Centers for Disease Control and Prevention. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States, May-August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1071-4.